Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 1
2002 1
2003 2
2005 1
2006 1
2008 1
2009 3
2010 4
2011 2
2012 4
2013 1
2015 1
2016 3
2017 1
2019 1
2020 4
2021 4
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Multimodal imaging in iodate-induced toxic retinopathy.
Çomçalı S, Yılmaz PT, Çavdarlı C, Alp MN. Çomçalı S, et al. Among authors: alp mn. Eur J Ophthalmol. 2021 Sep;31(5):NP78-NP82. doi: 10.1177/1120672120926862. Epub 2020 May 26. Eur J Ophthalmol. 2021. PMID: 32544986
Real Life Multicenter Comparison of 24-Month Outcomes of Anti-VEGF Therapy in Diabetic Macular Edema in Turkey: Ranibizumab vs. Aflibercept vs. Ranibizumab-Aflibercept Switch.
Kucukevcilioglu M, Yeşiltaş YS, Durukan AH, Unlu N, Onen M, Alp MN, Kalayci D, Acar MA, Sekeroglu MA, Citirik M, Altintas AGK, Hazirolan D, Ozdal PC, Toklu Y, Bicer T, Ugurlu N, Budakoglu O, Yazar Z, Zeki NIU, Serdar K, Doguizi S, Erol YO, Atilgan CU, Yorgun MA, Soba DO, Berker N, Baskan C. Kucukevcilioglu M, et al. Among authors: alp mn. Medicina (Kaunas). 2023 Jan 30;59(2):263. doi: 10.3390/medicina59020263. Medicina (Kaunas). 2023. PMID: 36837465 Free PMC article.
Anti-vascular endothelial growth factor therapy in diabetic macular edema: real-life outcomes from a multicenter study in Turkey over 36 months.
Durukan AH, Unlu N, Onen M, Alp MN, Yeşiltaş YS, Kalayci D, Acar MA, Sekeroglu MA, Citirik M, Altintas AGK, Hazirolan D, Kucukevcilioglu M, Ozdal PC, Toklu Y, Bicer T, Ugurlu N, Budakoglu O, Yazar Z, Ucgun NI, Serdar K, Doguizi S, Erol YO, Atilgan CU, Yorgun MA, Soba DO, Berker N, Baskan C, Yilmaz ES. Durukan AH, et al. Among authors: alp mn. Int Ophthalmol. 2022 Dec;42(12):3777-3787. doi: 10.1007/s10792-022-02375-6. Epub 2022 Jul 13. Int Ophthalmol. 2022. PMID: 35829865
Viscocanalostomy with mitomycin-C: a preliminary study.
Yarangümeli A, Köz OG, Alp MN, Elhan AH, Kural G. Yarangümeli A, et al. Among authors: alp mn. Eur J Ophthalmol. 2005 Mar-Apr;15(2):202-8. doi: 10.1177/112067210501500204. Eur J Ophthalmol. 2005. PMID: 15812760 Clinical Trial.
37 results